| scholarly article | Q13442814 |
| P2093 | author name string | John P Loftus | |
| Seth A Peng | |||
| Phillip J Mick | |||
| P2860 | cites work | Vitamin D deficiency | Q27860616 |
| DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
| Vitamin D intake and incidence of multiple sclerosis | Q34289402 | ||
| A Nonsecosteroidal Vitamin D Receptor Modulator Ameliorates Experimental Autoimmune Encephalomyelitis without Causing Hypercalcemia | Q34557334 | ||
| 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes | Q34624558 | ||
| Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? | Q34660000 | ||
| Vitamin D-binding protein controls T cell responses to vitamin D. | Q35259198 | ||
| Low Vitamin D Status Is Associated with Systemic and Gastrointestinal Inflammation in Dogs with a Chronic Enteropathy | Q35762625 | ||
| The effect of diet on serum 25-hydroxyvitamin D concentrations in dogs | Q35776710 | ||
| 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region | Q35981603 | ||
| Hypovitaminosis D is associated with negative outcome in dogs with protein losing enteropathy: a retrospective study of 43 cases | Q36340880 | ||
| Vitamin D and rheumatoid arthritis | Q36515194 | ||
| Cats with inflammatory bowel disease and intestinal small cell lymphoma have low serum concentrations of 25-hydroxyvitamin D. | Q36873412 | ||
| Relation of vitamin D status to congestive heart failure and cardiovascular events in dogs | Q36975263 | ||
| Oral vitamin D supplementation at five times the recommended allowance marginally affects serum 25-hydroxyvitamin D concentrations in dogs | Q37156844 | ||
| CXCL10: a candidate biomarker in transplantation. | Q37988245 | ||
| The implication of vitamin D and autoimmunity: a comprehensive review | Q38077485 | ||
| Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease. | Q38097111 | ||
| Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation | Q38108294 | ||
| Vitamin D effects on B cell function in autoimmunity | Q38206792 | ||
| High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells | Q39356640 | ||
| Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages | Q40887948 | ||
| Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy. | Q41075307 | ||
| Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences | Q41941097 | ||
| Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure | Q44587098 | ||
| Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells | Q46241666 | ||
| The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis | Q46519289 | ||
| Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. | Q46677379 | ||
| Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study | Q48061784 | ||
| Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia. | Q51057688 | ||
| 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. | Q52607615 | ||
| Vitamin D Receptor Expression in Dogs | Q57101516 | ||
| Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target | Q59813820 | ||
| Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations | Q70336407 | ||
| Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D | Q72510311 | ||
| Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants | Q73832066 | ||
| Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop | Q79346423 | ||
| Vitamin D deficiency in patients with active systemic lupus erythematosus | Q81577955 | ||
| Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial | Q86247732 | ||
| Hypovitaminosis D in dogs with spirocercosis | Q87266978 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 247 | |
| P577 | publication date | 2019-07-30 | |
| P1433 | published in | Frontiers in Veterinary Science | Q27726928 |
| P1476 | title | Serum Vitamin D Metabolites and CXCL10 Concentrations Associate With Survival in Dogs With Immune Mediated Disease | |
| P478 | volume | 6 |
| Q99562840 | Vitamin D Metabolism and Profiling in Veterinary Species | cites work | P2860 |
Search more.